Aurobindo Pharma USA is recalling 9,504 bottles of medication used to treat high blood pressure from the US market, the US Food and Drug Administration (USFDA) said. The lot has been recalled due to "current good manufacturing practices CGMP deviations," USFDA added. The recalled Quinapril and Hydrochlorothiazide tablets were manufactured in India and marketed in US by Aurobindo Pharma USA.